Advanced search
Publication Cover
International Journal of Nanomedicine Volume 17, 2023 - Issue
Submit an article Journal homepage
226
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Direct Detection of Pulmonary Fibrosis by Near-Infrared-Responsive Biomimetic Platelets

Guanlie Li1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Haiqing He1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Guodong Zheng1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Wenjing Jiang1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Shuwen Du1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Hua Tao1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Tao Xiao1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Dazhi Zhou2 Department of Ultrasound, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Shangwei Ding2 Department of Ultrasound, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Xi-Yong Yu1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
,
Yu Zhang1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
&
Ao Shen1 Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-1559-3895
ORCID Icon show all
Pages 151-162 | Published online: 10 Jan 2022

References

  • Kolahian S, Fernandez IE, Eickelberg O, et al. Immune mechanisms in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2016;55(3):309–322.
  • Martinez FJ, Collard HR, Pardo A, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017;3:17074.
  • Somogyi V, Chaudhuri N, Torrisi SE, et al. The therapy of idiopathic pulmonary fibrosis: what is next? Eur Respir Rev. 2019;28(153):190021.
  • Smith JS, Gorbett D, Mueller J, et al. Pulmonary hypertension and idiopathic pulmonary fibrosis: a dastardly duo. Am J Med Sci. 2013;346(3):221–225.
  • George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807–815.
  • Muzard J, Sarda-Mantel L, Loyau S, et al. Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI. PLoS One. 2009;4(5):e5585.
  • Caravan P, Yang Y, Zachariah R, et al. Molecular magnetic resonance imaging of pulmonary fibrosis in mice. Am J Respir Cell Mol Biol. 2013;49(6):1120–1126.
  • Désogère P, Tapias LF, Rietz TA, et al. Optimization of a collagen-targeted PET probe for molecular imaging of pulmonary fibrosis. J Nucl Med. 2017;58(12):1991–1996.
  • Montesi SB, Izquierdo-Garcia D, Désogère P, et al. Type I collagen-targeted positron emission tomography imaging in idiopathic pulmonary fibrosis: first-in-human Studies. Am J Respir Crit Care Med. 2019;200(2):258–261.
  • van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16(3):166–179.
  • Gros A, Ollivier V, Ho-Tin-Noé B. Platelets in inflammation: regulation of leukocyte activities and vascular repair. Front Immunol. 2015;5:678.
  • Chen HY, Deng J, Wang Y, et al. Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy. Acta Biomater. 2020;112:1–13.
  • Gao L, Wang H, Nan L, et al. Erythrocyte membrane-wrapped pH sensitive polymeric nanoparticles for non-small cell lung cancer therapy. Bioconjug Chem. 2017;28(10):2591–2598.
  • Tang J, Su T, Huang K, et al. Targeted repair of heart injury by stem cells fused with platelet nanovesicles. Nat Biomed Eng. 2018;2:17–26.
  • Zhang L, Deng S, Zhang Y, et al. Homotypic targeting delivery of siRNA with artificial cancer cells. Adv Healthc Mater. 2020;9(9):e1900772.
  • Huang X, Shen A, Peng R, et al. A novel biomimetic nanoprobe as photoacoustic contrast agent. Front. Chem. 2021;9:721799.
  • Hu CM, Fang RH, Wang KC, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526(7571):118–121.
  • Jung H, Kang YY, Mok H. Platelet-derived nanovesicles for hemostasis without release of pro-inflammatory cytokines. Biomater Sci. 2019;7(3):856–859.
  • Chen M, Wang P, Jiang D, et al. Platelet membranes coated gold nanocages for tumor targeted drug delivery and amplificated low-dose radiotherapy. Front Oncol. 2021;11:793006.
  • Wang S, Duan Y, Zhang Q, et al. Drug targeting via platelet membrane-coated nanoparticles. Small Struct. 2020;1(1):2000018.
  • Molteni A, Ward WF, Ts’ao CH, et al. Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine. Proc Soc Exp Biol Med. 1985;180(1):112–120.
  • Baybutt RC, Herndon BL, Umbehr J, et al. Effects on cytokines and histology by treatment with the ACE inhibitor captopril and the antioxidant retinoic acid in the monocrotaline model of experimentally induced lung fibrosis. Curr Pharm Des. 2007;13(13):1327–1333.
  • Jessen H, Hoyer N, Prior TS, et al. Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis. Respir Res. 2021;22(1):205.
  • Ai X, Duan Y, Zhang Q, et al. Cartilage-targeting ultrasmall lipid-polymer hybrid nanoparticles for the prevention of cartilage degradation. Bioeng Transl Med. 2020;6(1):e10187.
  • Fujisaki H, Futaki S, Mizuno K, et al. Evaluation of keratinocyte proliferation on two- and three-dimensional type I collagen substrates. J Vis Exp. 2019;146:e59339.
  • Yao S, Xu Y, Shao C, et al. A biomimetic model for mineralization of type-I collagen fibrils. Methods Mol Biol. 2019;1944:39–54.
  • Su Y, Yu B, Wang S, et al. NIR-II bioimaging of small organic molecule. Biomaterials. 2021;271:120717.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.